Skip to main content
. 2020 Feb 4;10:33. doi: 10.3389/fonc.2020.00033

Figure 2.

Figure 2

PLXNC1 predicts prognosis in gastric cancer. (A) The differential expression level of PLXNC1 expressed in our 111 paired STAD tissues. (B,C) Kaplan–Meier curves of overall survival and disease-free survival in our internal 111 gastric patients, validated by PLXNC1 mRNA expression levels. (D) The results of multi-variate analyses using the Cox proportional hazard regression model for PLXNC1 mRNA levels and other clinical indices in our internal cohort. (E) The comparison of diagnostic efficacy of CEA and PLXNC1 mRNA levels for predicting the time period of tumor OS. *P < 0.05; **P < 0.01.